Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Satsuma Pharmaceuticals Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-11-24
Purchase
2021-11-29
4:30 pm
Satsuma Pharmaceuticals Inc. STSA COMMODORE CAPITAL LP
10% Owner
2,922 $5.42 $15,837 3,711,286
(Indirect)
View
2021-11-19
Purchase
2021-11-23
4:30 pm
Satsuma Pharmaceuticals Inc. STSA COMMODORE CAPITAL LP
10% Owner
13,204 $5.4778 $72,329 3,708,364
(Indirect)
View
2021-11-10
Purchase
2021-11-12
4:31 pm
Satsuma Pharmaceuticals Inc. STSA COMMODORE CAPITAL LP
10% Owner
17,563 $5.9404 $104,332 3,695,160
(Indirect)
View
2021-11-08
Purchase
2021-11-10
4:30 pm
Satsuma Pharmaceuticals Inc. STSA COMMODORE CAPITAL LP
10% Owner
560 $5.99 $3,354 3,677,597
(Indirect)
View
2021-11-04
Purchase
2021-11-08
4:33 pm
Satsuma Pharmaceuticals Inc. STSA COMMODORE CAPITAL LP
10% Owner
9,200 $5.9393 $54,642 3,677,037
(Indirect)
View
2021-11-02
Purchase
2021-11-04
4:31 pm
Satsuma Pharmaceuticals Inc. STSA COMMODORE CAPITAL LP
10% Owner
8,880 $5.64 $50,083 3,667,837
(Indirect)
View
2021-10-29
Purchase
2021-11-02
4:30 pm
Satsuma Pharmaceuticals Inc. STSA COMMODORE CAPITAL LP
10% Owner
44,651 $5.71 $254,957 3,658,957
(Indirect)
View
2021-10-27
Purchase
2021-10-29
4:30 pm
Satsuma Pharmaceuticals Inc. STSA COMMODORE CAPITAL LP
10% Owner
54,663 $5.4776 $299,422 3,614,306
(Indirect)
View
2021-10-21
Purchase
2021-10-25
4:31 pm
Satsuma Pharmaceuticals Inc. STSA COMMODORE CAPITAL LP
10% Owner
60,445 $5.4503 $329,442 3,559,643
(Indirect)
View
2021-10-19
Purchase
2021-10-21
4:30 pm
Satsuma Pharmaceuticals Inc. STSA COMMODORE CAPITAL LP
10% Owner
128,243 $5.1873 $665,237 3,499,198
(Indirect)
View
2021-10-15
Purchase
2021-10-19
5:13 pm
Satsuma Pharmaceuticals Inc. STSA COMMODORE CAPITAL LP
10% Owner
162,194 $4.8389 $784,845 3,370,955
(Indirect)
View
2021-02-26
Purchase
2021-03-02
4:30 pm
Satsuma Pharmaceuticals Inc. STSA RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
1,232,394 $5.68 $6,999,998 5,155,854
(Indirect)
View
2020-09-01
Sale
2020-09-03
4:06 pm
Satsuma Pharmaceuticals Inc. STSA ALBRECHT DETLEF
Chief Medical Officer
1,000 $22.21 $22,210 87,680
(Direct)
View
2020-09-01
Sale
2020-09-03
4:05 pm
Satsuma Pharmaceuticals Inc. STSA O'Neil Thomas P.
CFO
750 $22.19 $16,645 65,590
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-03
Option Award
2022-06-07
5:40 pm
N/A
2032-06-02
Satsuma Pharmaceuticals Inc. STSA O'Neil Thomas P.
CFO
190,000 $0 190,000
(Direct)
View
2022-06-03
Option Award
2022-06-07
5:39 pm
N/A
2032-06-02
Satsuma Pharmaceuticals Inc. STSA ALBRECHT DETLEF
Chief Medical Officer
190,000 $0 190,000
(Direct)
View
2022-06-03
Option Award
2022-06-07
5:38 pm
N/A
2032-06-02
Satsuma Pharmaceuticals Inc. STSA Kollins John A
CEO
505,000 $0 505,000
(Direct)
View
2022-06-03
Option Award
2022-06-07
5:38 pm
N/A
2032-06-02
Satsuma Pharmaceuticals Inc. STSA Lukatch Heath
Director
30,000 $0 30,000
(Direct)
View
2022-06-03
Option Award
2022-06-07
5:37 pm
N/A
2032-06-02
Satsuma Pharmaceuticals Inc. STSA Sandoval Elisabeth
Director
30,000 $0 30,000
(Direct)
View
2022-06-03
Option Award
2022-06-07
5:36 pm
N/A
2032-06-02
Satsuma Pharmaceuticals Inc. STSA TAKANASHI KEN
Director
30,000 $0 1,591,719
(Direct)
View
2022-06-03
Option Award
2022-06-07
5:36 pm
N/A
2032-06-02
Satsuma Pharmaceuticals Inc. STSA Harsch Mutya
Director
30,000 $0 30,000
(Direct)
View
2022-06-03
Option Award
2022-06-07
5:35 pm
N/A
2032-06-02
Satsuma Pharmaceuticals Inc. STSA Soloway Thomas P
Director
30,000 $0 30,000
(Direct)
View
2022-06-03
Option Award
2022-06-07
5:34 pm
N/A
2032-06-02
Satsuma Pharmaceuticals Inc. STSA KING THOMAS BRAXTON
Director
30,000 $0 30,000
(Direct)
View
2022-06-03
Option Award
2022-06-07
5:34 pm
N/A
2032-06-02
Satsuma Pharmaceuticals Inc. STSA Riebe Michael T
Director
30,000 $0 30,000
(Direct)
View
2022-06-03
Option Award
2022-06-07
5:31 pm
N/A
2032-06-02
Satsuma Pharmaceuticals Inc. STSA RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
30,000 $0 30,000
(Indirect)
View
2021-10-14
Ownership
2021-10-19
5:09 pm
N/A
N/A
Satsuma Pharmaceuticals Inc. STSA COMMODORE CAPITAL LP
10% Owner
0 $0 3,208,761
(Indirect)
View
2021-10-11
Option Award
2021-10-12
5:17 pm
N/A
2031-10-11
Satsuma Pharmaceuticals Inc. STSA Harsch Mutya
Director
40,000 $0 40,000
(Direct)
View
2021-04-01
Other
2021-04-05
4:34 pm
N/A
N/A
Satsuma Pharmaceuticals Inc. STSA RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
758,398 $5.91 6,106,639
(Indirect)
View
2020-12-03
Option Award
2020-12-07
6:26 pm
N/A
2030-12-03
Satsuma Pharmaceuticals Inc. STSA RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Director
10% Owner
20,000 $0 20,000
(Indirect)
View
2020-12-03
Option Award
2020-12-07
6:07 pm
N/A
2030-12-03
Satsuma Pharmaceuticals Inc. STSA KING THOMAS BRAXTON
Director
20,000 $0 20,000
(Direct)
View
2020-12-03
Option Award
2020-12-07
6:06 pm
N/A
2030-12-03
Satsuma Pharmaceuticals Inc. STSA Riebe Michael T
Director
20,000 $0 20,000
(Direct)
View
2020-12-03
Option Award
2020-12-07
6:05 pm
N/A
2030-12-03
Satsuma Pharmaceuticals Inc. STSA TAKANASHI KEN
Director
20,000 $0 1,581,719
(Direct)
View
2020-12-03
Option Award
2020-12-07
6:04 pm
N/A
2030-12-03
Satsuma Pharmaceuticals Inc. STSA Lukatch Heath
Director
20,000 $0 20,000
(Direct)
View
2020-12-03
Option Award
2020-12-07
6:04 pm
N/A
2030-12-03
Satsuma Pharmaceuticals Inc. STSA Sandoval Elisabeth
Director
20,000 $0 20,000
(Direct)
View
2020-12-03
Option Award
2020-12-07
6:03 pm
N/A
2030-12-03
Satsuma Pharmaceuticals Inc. STSA Soloway Thomas P
Director
20,000 $0 20,000
(Direct)
View
2020-12-03
Option Award
2020-12-07
6:02 pm
N/A
2030-12-03
Satsuma Pharmaceuticals Inc. STSA O'Neil Thomas P.
CFO
80,000 $0 80,000
(Direct)
View
2020-12-03
Option Award
2020-12-07
6:02 pm
N/A
2030-12-03
Satsuma Pharmaceuticals Inc. STSA Kollins John A
CEO
240,000 $0 240,000
(Direct)
View
2020-12-03
Option Award
2020-12-07
6:01 pm
N/A
2030-12-03
Satsuma Pharmaceuticals Inc. STSA ALBRECHT DETLEF
Chief Medical Officer
80,000 $0 80,000
(Direct)
View
2020-12-03
Option Award
2020-12-07
6:00 pm
N/A
2030-12-03
Satsuma Pharmaceuticals Inc. STSA Shah Rajeev M.
Director
10% Owner
20,000 $0 20,000
(Direct)
View
2020-09-01
Exercise
2020-09-03
4:06 pm
N/A
N/A
Satsuma Pharmaceuticals Inc. STSA ALBRECHT DETLEF
Chief Medical Officer
1,000 $4.56 87,680
(Direct)
View
2020-09-01
Exercise
2020-09-03
4:05 pm
N/A
N/A
Satsuma Pharmaceuticals Inc. STSA O'Neil Thomas P.
CFO
750 $4.56 65,590
(Direct)
View
2020-09-01
Exercise
2020-09-03
4:05 pm
N/A
2029-05-16
Satsuma Pharmaceuticals Inc. STSA O'Neil Thomas P.
CFO
750 $0 65,590
(Direct)
View
Goto 0, 1, 2, Next